The gut is where GLP-1 weight loss starts, and where it stalls

A Harvard gastroenterologist describes the gut as the body's appetite organ. After a meal it releases hormones that signal fullness and steady blood sugar, its microbes live on fiber, and a thin lining keeps both in check. When fiber runs short, those microbes feed on the protective mucus layer.

That frame explains why GLP-1 medicines work and where they fall short. Weight often returns after stopping, part of the loss can be muscle, and side effects can include a flattening of drive. Drugs that act on several gut hormones at once, such as retatrutide, and endoscopic procedures that may let a lower dose go further are framed as next steps.

Several of these ideas, including resurfacing the lining of the small intestine to hold weight off after a GLP-1 ends, are early research, some not yet published. Treatment choices belong with a clinician who knows the person's history.

Read the full story at Huberman Lab ↗